GF
TSVT

Gabelli Funds’s 2seventy bio TSVT Stock Holding History

Gabelli Funds’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-252,500
Closed -$1.25M – 1242
2025
Q1 		$1.25M Buy
+252,500
New +$802K 0.01% 742
2023
Q2 		– Sell
-10,433
Closed -$106K – 1155
2023
Q1 		$106K Hold
10,433
– – ﹤0.01% 1063
2022
Q4 		$97.8K Sell
10,433
-1,167
-10% -$16.5K ﹤0.01% 1109
2022
Q3 		$169K Hold
11,600
– – ﹤0.01% 1171
2022
Q2 		$153K Hold
11,600
– – ﹤0.01% 1211
2022
Q1 		$198K Sell
11,600
-460
-4% -$7.8K ﹤0.01% 1247
2021
Q4 		$309K Buy
+12,060
New +$376K ﹤0.01% 1171

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's TSVT Position: Q2 2025 in Review

Gabelli Funds sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 252,500 shares — an estimated $1.25M sold.

Gabelli Funds first reported a position in TSVT in Q4 2021 and held it in 7 quarters. The position peaked at $1.25M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Gabelli Funds reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Gabelli Funds sold 252,500 2seventy bio shares in Q2 2025, an estimated $1.25M.
  • Gabelli Funds first reported a position in 2seventy bio in Q4 2021 and held it in 7 quarters.
  • Gabelli Funds's 2seventy bio position peaked at $1.25M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.